EM2103H "Bones of Contention: Osteoporosis 2021" (IM GR-032621)

The purpose of this lecture is to discuss the new anabolic drugs, the controversies of the use of calcium and vitamin D, as well as the new guidelines of diagnosing Osteoporosis. In addition, we will discuss the modifiable risk factors of Osteoporosis.

Target Audience

The purpose of this lecture is to discuss the new anabolic drugs, the controversies of the use of calcium and vitamin D, as well as the new guidelines of diagnosing Osteoporosis. In addition, we will discuss the modifiable risk factors of Osteoporosis.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Review controversies around calcium and vitamin D supplements.
  • Discuss potential long-term effects of continuing or stopping bisphosphonates and denosumab.
  • Understand newer anabolic approaches to Osteoporosis.
  • Critique the latest Osteoporosis guidelines.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
03/31/2021
Course expires: 
04/30/2021
Cost:
$0.00
Rating: 
0

Ken Saag, M.D., MSc
Jane Knight Lowe Professor and Vice Chairman
Director, Division of Clinical Immunology and Rheumatology
Director, Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center
Department of Medicine
University of Alabama at Birmingham
Ray A. and Robert L. Kroc Lectureship in Rheumatology

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome